GeneDx

Being recognized by @FastCompany’s Most Innovative Companies proves that pushing boundaries and always innovating is the path towards making sure people receive the care they need to live their fullest life.

We’re proud to partner with @GeneDx to launch a Sponsored Genetic Testing Program for eligible patients in the U.S. with suspected Niemann-Pick disease type C (NPC). Read the press release: businesswire.com/news/home/2026… #RareDisease #NPC #GeneticTesting

Rare disease isn’t rare. It’s one of healthcare’s biggest blind spots. In @FastCompany Impact Council, our CMO Linda Genen, MD, MPH shares why genomics can shorten years to days and bring clarity to care. Read more → genedx.co/4b8Tuli

The countdown is officially on! In just 5 days, curious minds, bold ideas, and big neonatal questions collide at Delphi 2026 in Fort Lauderdale.✨🎤 If you're not able to join us in person, be sure to follow along on our social media; we will be sharing live updates throughout. 🙌 Huge thank you to our amazing exhibitors and sponsors. We couldn't have done this without your support: → @ChiesiGroup → @DrBrownsMedical → @GEHealthCare → @Pampers → @NSUFlorida → @prolacta → @meadjohnson → @Nicklaus4Kids → @ONYBiotech → @CergenX → @neurobell_ → @Nemours → @GeneDx → @VTOxfordNetwork → @AbbottNews → @LABORIEMEDICAL → @MarchofDimes → @visitlauderdale #DelphiConference2026 #NeonatalInnovation

In this short video, Mimi C. Lee, MD, PhD, explains the mechanism of whole genome and exome testing, highlighting @GeneDx's ExomeDx test and GenomeDx tests. Watch the full interview with Lee, and learn more about genetic testing: contemporarypediatrics.com/view/mimi-c-le…

Katherine Stueland, CEO of @GeneDx, on using early genomics to end the diagnostic odyssey and bring answers to more families. Apple: hubs.ly/Q03WKvxB0 Spotify: hubs.ly/Q03WKwJs0 Acast: hubs.ly/Q03WKrqy0 #Genomics #PrecisionMedicine #RareDisease #screening

Up to 50% of unexplained epilepsy cases have a genetic cause, yet many go undetected. Dr. Isabella Herman of Boys Town National Research Hospital shares how genetic testing is transforming epilepsy care. This #EpilepsyAwarenessMonth, we’re teaming with @GeneDx to highlight how genetic testing can uncover the root cause of seizures and help providers deliver more precise, personalized care.

👏 Thrilled to have @GeneDx join #FierceHealthPayerSummit 2025 as a Gold Partner! Dec 3–5 in Nashville — payers, providers & innovators unite to address prior authorization & health equity. Details: loom.ly/hpmW45g #HealthPayer

@GeneDx is making waves at NSGC 2025! Showcasing breakthroughs in genomics & precision medicine. Read Complete News at: towardshealthcare.com/news/genedx-ns… #MedicalInnovation #GenomicsResearch #Genomics #PrecisionMedicine #NSGC2025 #HealthcareInnovation

Howard McLeod Started a New Position as Senior Vice President of Clinical Affairs at GeneDx @mcleodhoward @GeneDx oncodaily.com/career/howard-… #Cancer #Medicine #Health #Oncology #OncoDaily #GeneDx #MedX #MedNews #MedEd

Fabric Genomics and @GeneDx are enabling decentralized testing powered by centralized intelligence. Together, we harness the power of data to deliver actionable genomic insights. Visit us at #ASHG2025 bit.ly/3KMkVGW #WGS

What’s next for #GeneTherapy and #CellTherapy? #NORD + @ASGCTherapy co-hosted a #NORDSummit panel on promising, cutting-edge science—and the challenges of access, affordability and equity. Featuring experts from @UMassChan and @GeneDx. Patient voices + FUNDING = New treatments

At ASHG, Illumina Pilots Products for Mapped Reads, Multiomics The company shared pilot data about its Constellation tech and released 5-Base, a product for jointly analyzing genetic and epigenetic data @illumina @GeneDx #multiomics #DNAmethylation #ASHG hubs.li/Q03P9lZl0

We’ve spent years pushing the limits of what short-read sequencing can do. Now, with our emerging constellation mapped read technology, we’re breaking new barriers and enabling the industry to uncover even deeper insights from the genome. @GeneDx recently piloted constellation to evaluate its performance in the most challenging genomic regions. Early results illustrate its ability to rapidly identify hard-to-detect variants implicated in rare disease, like DMPK, SMN1, and mosaic aneuploidy. Joe Devaney, Director of the Laboratory Innovation Team at GeneDx, said: “We’re continually looking to advance research and clinical genomics to drive the future of precision medicine and better health outcomes for all. The level of detail we can achieve with Constellation provides promising insight into some of the world’s most complex and difficult-to-diagnose diseases.” Constellation delivers long-range genomic insights with a simplified, on-flow-cell library prep that removes manual steps — all within the workflows our customers know and trust. 📍GeneDx presented the results of their pilot today at #ASHG25. Read more here: bit.ly/4oaVLkh

Reminder: Our first #ASHG25 CoLab starts in one hour in CoLab Theater 1! Hear from @GeneDx and @UMich on how #PacBio PureTarget enables PCR-free HiFi sequencing for challenging genes, germline diagnostics, and disease research panels. Don’t miss out!

.@EinsteinMed is joining BEACONS—the first multi-state pilot initiative to integrate whole genome sequencing into standard newborn screening and study how it can identify genetic conditions in the first year of life. @GeneDx @MassGenBrigham ir.genedx.com/news-releases/…

Meet this year’s #NORDSummit Lightning Round Poster Presenters! Featuring top #RareDisease research from @medliveofficial, @CureCastleman, @GeneDx, @AFTDHope, @AlexionPharma & @ArrowheadPharma. Register to attend on Oct. 20 to learn about their work! 👉 bit.ly/4lSAkDq

SAVE THE DATE! With global developmental delay (GDD) & intellectual disability (ID) now affecting more than 8% of children in the US, staying current on genetic diagnosis is critical. Join our live event. 🗓️ September 18, 2025 ⏰ 1:30 PM EDT ➡️ youtube.com/watch?v=OrsM4V… #CME

"Earlier testing gives families and clinicians more options," says @GeneDx CEO Katherine Stueland on the fight against rare diseases. cnb.cx/3H1DPrS

Come along to The Festival of Genomics & Biodata, Boston to hear from Mahmoud Husseini (VP, Head of Biopharma Partnerships, @GeneDx) on real world genomic data and disease prevalence. Register now: hubs.la/Q03rRd1D0 #FOGBoston

@GeneDx just crowned #CerebralPalsy as a genetic testing priority - every CP dx deserves a genetic test. Listen to the episode: effieparks.com/podcast/genedx